Tumor Immunotherapy
T Cell Activation and Clonal Selection
Cytotoxic T Cells-mediated Immune Response
The Tumor Microenvironment
Cell-mediated Immune Responses
Cancer Stem Cells and Tumor Maintenance
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 23, 2026

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
Published on: August 1, 2025
Ying Cai1,2, Jiameng Chen1,2, Yaping Li1,2
1State Key Laboratory of Drug Research and Center of Pharmaceutics, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China.
No abstract available in PubMed .